These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Insights into the mechanism of action and cellular targets of ruthenium complexes from NMR spectroscopy. Giannini F; Paul LE; Furrer J Chimia (Aarau); 2012; 66(10):775-80. PubMed ID: 23146264 [TBL] [Abstract][Full Text] [Related]
24. Detecting DNA mismatches with metallo-insertors: a molecular simulation study. Vargiu AV; Magistrato A Inorg Chem; 2012 Feb; 51(4):2046-57. PubMed ID: 22288501 [TBL] [Abstract][Full Text] [Related]
25. Speciation of Metal Complexes of Medicinal Interest: Relationship between Solution Equilibria and Pharmaceutical Properties. Kiss T; Enyedy ÉA; Jakusch T; Dömötör O Curr Med Chem; 2019; 26(4):580-606. PubMed ID: 29521198 [TBL] [Abstract][Full Text] [Related]
26. Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling. Oehninger L; Spreckelmeyer S; Holenya P; Meier SM; Can S; Alborzinia H; Schur J; Keppler BK; Wölfl S; Ott I J Med Chem; 2015 Dec; 58(24):9591-600. PubMed ID: 26595649 [TBL] [Abstract][Full Text] [Related]
27. Polyamine quinoline rhodium complexes: synthesis and pharmacological evaluation as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis. Stringer T; Taylor D; Guzgay H; Shokar A; Au A; Smith PJ; Hendricks DT; Land KM; Egan TJ; Smith GS Dalton Trans; 2015 Sep; 44(33):14906-17. PubMed ID: 26226082 [TBL] [Abstract][Full Text] [Related]
28. Technologies to develop new metal medicines. Dufrasne F Drug Discov Today Technol; 2015 Sep; 16():31-2. PubMed ID: 26547419 [No Abstract] [Full Text] [Related]
29. Photocatalytic production of hydrogen by disproportionation of one-electron-reduced rhodium and iridium-ruthenium complexes in water. Fukuzumi S; Kobayashi T; Suenobu T Angew Chem Int Ed Engl; 2011 Jan; 50(3):728-31. PubMed ID: 21226164 [No Abstract] [Full Text] [Related]
30. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani. Croft SL; Neal RA; Craciunescu DG; Certad-Fombona G Trop Med Parasitol; 1992 Mar; 43(1):24-8. PubMed ID: 1598504 [TBL] [Abstract][Full Text] [Related]
31. Antifungal activity of rhodium, iridium, and ruthenium tripodal phosphine complexes. Sülü M; Küçükbay H; Durmaz R; Günal S New Microbiol; 2000 Jan; 23(1):73-8. PubMed ID: 10946408 [TBL] [Abstract][Full Text] [Related]
36. Perspective: the potential of pyrazole-based compounds in medicine. Keter FK; Darkwa J Biometals; 2012 Feb; 25(1):9-21. PubMed ID: 22002344 [TBL] [Abstract][Full Text] [Related]
37. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells. Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751 [TBL] [Abstract][Full Text] [Related]
38. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs. Liu W; Gust R Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001 [TBL] [Abstract][Full Text] [Related]
39. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes. Hartinger CG Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595 [No Abstract] [Full Text] [Related]
40. Antagonizing STAT3 dimerization with a rhodium(III) complex. Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]